UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction

Circulation (New York, N.Y.), 2006-06, Vol.113 (25), p.2906-2913

2006

Link zum Volltext

Verfügbarkeit prüfen

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction

European heart journal, 2006-05, Vol.27 (10), p.1153-1158

2006

Link zum Volltext

Verfügbarkeit prüfen

Competing risks as a multi-state model

Statistical methods in medical research, 2002-04, Vol.11 (2), p.203-215

2002

Link zum Volltext

Verfügbarkeit prüfen

SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data

Computer methods and programs in biomedicine, 2004-04, Vol.74 (1), p.69-75

2004

Link zum Volltext

Verfügbarkeit prüfen

The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years

European heart journal, 2005-01, Vol.26 (2), p.145-152

2005

Link zum Volltext

Verfügbarkeit prüfen

QT dynamics in risk stratification after myocardial infarction

Heart rhythm, 2005-04, Vol.2 (4), p.357-364

2005

Link zum Volltext

Verfügbarkeit prüfen

A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction

European journal of heart failure, 2004-12, Vol.6 (7), p.927-935

2004

Link zum Volltext

Verfügbarkeit prüfen

Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation

Journal of internal medicine, 2006-02, Vol.259 (2), p.173-178

2006

Link zum Volltext

Verfügbarkeit prüfen

Sudden cardiovascular death following myocardial infarction: The importance of left ventricular systolic dysfunction and congestive heart failure

International journal of cardiology, 2005-09, Vol.104 (2), p.184-189

2005

Link zum Volltext

Verfügbarkeit prüfen

Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002

International journal of food sciences and nutrition, 2005-04, Vol.39 (1-2), p.42-49

2005

Link zum Volltext

Verfügbarkeit prüfen

Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction-a meta-analysis

European journal of heart failure, 2006-01, Vol.8 (1), p.90-96

2006

Link zum Volltext

Verfügbarkeit prüfen

Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure

Archives of internal medicine (1960), 2009-01, Vol.169 (2), p.141

2009

Link zum Volltext

Verfügbarkeit prüfen

The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function

European heart journal, 2003-12, Vol.24 (23), p.2116-2122

2003

Link zum Volltext

Verfügbarkeit prüfen

Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patient characteristics of the DIAMOND studies

Clinical cardiology (Mahwah, N.J.), 1997-08, Vol.20 (8), p.704-710

Mosller, M

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 14 von 14

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction

Competing risks as a multi-state model

SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data

The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years

QT dynamics in risk stratification after myocardial infarction

A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction

Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation

Sudden cardiovascular death following myocardial infarction: The importance of left ventricular systolic dysfunction and congestive heart failure

Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002

Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction-a meta-analysis

Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure

The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function

Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patient characteristics of the DIAMOND studies

Aktive Filter

Suchergebnisse filtern